Biomedical Advanced Research and Development Authority
#biomedical-advanced-research-and-development-authority
government organization in Washington D.C., United States
Irish team develop therapy for deadly sepsis crisis : Inthelia Therapeutics, founded by two top Irish scientists, is switching focus to block infection getting a ...
irishtimes.com/business/innovation/2024/04/18/irish-team-develop-therapy-for-deadly-sepsis-crisis/
HHS awards $1.4B in grants to develop future COVID-19 tools: The Biden administration on Tuesday announced it is awarding $1.4 billion in grants through its ...
thehill.com/policy/healthcare/4164704-hhs-awards-1-4b-in-grants-to-develop-future-covid-19-tools/
Exclusive: Inside HHS' plan to develop next-generation COVID treatments: HHS is pouring billions of dollars into the development of future coronavirus ...
axios.com/2023/05/11/hhs-barda-covid-plan-beyond-phe
What to Know About Covid Tests and Treatment as the Public Health Emergency Ends: The emergency expired May 11, complicating access to tests and treatment in the ...
nytimes.com/2023/02/01/well/live/covid-public-health-emergency.html
Neil Vora: ‘The Last of Us’ is right. Our warming planet is a Petri dish. : Neil Vora writes that ‘The Last of Us’ is right. Our warming planet is a Petri dish.
sltrib.com/opinion/commentary/2023/04/10/neil-vora-last-us-is-right-our/
$24 billion could prepare the US to tackle every viral pandemic imaginable: The sum could prototype vaccines for all 26 known virus families that affect humans
qz.com/vaccine-prototypes-virus-families-24-billion-pandemic-1850424338
Paid articlePaid
Opinion | ‘The Last of Us’ Is Right. Our Warming Planet Is a Petri Dish.: Fungi are a public health blind spot.
nytimes.com/2023/04/02/opinion/the-last-of-us-fungus-climate-change.html
The potential and challenges of mucosal COVID-19 vaccines: In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) co-hosted a ...
medicalxpress.com/news/2023-04-potential-mucosal-covid-vaccines.html
Quick Glance: Exploring the Potential and Challenges of Mucosal COVID-19 Vaccines
- In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) organized a virtual workshop focusing on the development of mucosal vaccines for SARS-COV-2.
- The workshop findings have been published as a report in npj Vaccines.
- Researchers acknowledge the necessity for improvement as current COVID-19 vaccines, despite their ability to prevent severe diseases, hospitalizations, and deaths, could potentially be more effective in reducing virus replication and associated disease burden.
- A vaccine with better efficacy in preventing SARS-CoV-2 transmission or infection could significantly reduce virus replication and the related disease burden.
Richmond pharmaceutical company Phlow raises $36 million: Phlow Corp announced Wednesday that it had closed on a sizeable chunk of private investment dollars ...
richmond.com/business/local/richmond-pharmaceutical-phlow-corp-biden/article_b7dbb0bc-d4b3-11ed-8e01-dbde31d7d0ed.html
Moderna CEO says private investors funded COVID vaccine—not billions from gov’t: Bancel claimed billions in federal funding merely accelerated development.
arstechnica.com/science/2023/03/moderna-ceo-says-private-investors-funded-covid-vaccine-not-billions-from-govt/
San Antonio-based company a go-to developer of vaccines: The move is drawing attention to San Antonio’s growing health and bioscience industry.
expressnews.com/business/article/Texas-Biomed-federal-vaccines-17650915.php
Paid articlePaid
After Corona, the next pandemic will come at some point. That's why we talk to Bill Gates about important lessons from the current pandemic and look ahead: ... Show more https://trib.al/xQUwABR
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics